GAMMA Investing LLC Acquires 356 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

GAMMA Investing LLC grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 2.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 14,749 shares of the healthcare conglomerate’s stock after acquiring an additional 356 shares during the quarter. UnitedHealth Group accounts for about 0.6% of GAMMA Investing LLC’s holdings, making the stock its 18th largest position. GAMMA Investing LLC’s holdings in UnitedHealth Group were worth $7,461,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. GPM Growth Investors Inc. acquired a new position in shares of UnitedHealth Group during the 2nd quarter worth approximately $6,395,000. Stablepoint Partners LLC lifted its holdings in shares of UnitedHealth Group by 8.5% in the 2nd quarter. Stablepoint Partners LLC now owns 5,401 shares of the healthcare conglomerate’s stock worth $2,751,000 after purchasing an additional 424 shares in the last quarter. Mattern Capital Management LLC increased its holdings in UnitedHealth Group by 0.4% during the 2nd quarter. Mattern Capital Management LLC now owns 19,007 shares of the healthcare conglomerate’s stock worth $9,680,000 after purchasing an additional 77 shares in the last quarter. Arbor Trust Wealth Advisors LLC lifted its position in shares of UnitedHealth Group by 5.9% during the second quarter. Arbor Trust Wealth Advisors LLC now owns 2,713 shares of the healthcare conglomerate’s stock valued at $1,382,000 after purchasing an additional 150 shares in the last quarter. Finally, Commons Capital LLC boosted its stake in shares of UnitedHealth Group by 4.5% in the 2nd quarter. Commons Capital LLC now owns 3,770 shares of the healthcare conglomerate’s stock worth $1,920,000 after buying an additional 163 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

UNH has been the topic of several research reports. Cantor Fitzgerald boosted their target price on UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research note on Wednesday, October 16th. Stephens upped their target price on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. UBS Group decreased their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Finally, Oppenheimer boosted their price target on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. Three research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $628.37.

UnitedHealth Group Stock Performance

NYSE UNH opened at $504.51 on Friday. The stock has a 50-day moving average of $561.99 and a two-hundred day moving average of $560.42. The company has a market cap of $464.29 billion, a P/E ratio of 32.87, a P/E/G ratio of 1.53 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm’s revenue was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $6.56 earnings per share. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.66%. UnitedHealth Group’s payout ratio is currently 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.